Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

A new phase II clinical trial to evaluate Davanat with 5-FU in refractory colorectal cancer

Jan. 14, 2004

Widespread use of alternative medicine in prostate cancer patients

Jan. 14, 2004

IND filed for phase I ThermoDox trial for liver cancer

Jan. 14, 2004

Approval granted to an expanded use of Eloxatin for metastatic colorectal cancer in Europe

Jan. 13, 2004

Phase I/II trial of MTC-MMC in NSCLC cleared to begin

Jan. 13, 2004

New protein kinase inhibitors and their use in cancer therapy reported by Cytopia

Jan. 13, 2004

Novel KSP inhibitors identified by Merck researchers

Jan. 13, 2004

Two novel series of HDAC inhibitors discovered at Beacon

Jan. 12, 2004

Chemokine Therapeutics files for U.S. orphan drug designation for CTCE-9908

Jan. 9, 2004

U.S. enrollment commences for phase II SDX-105 study

Jan. 9, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.